MedPath

Study to reduce the oocyte degeneration rate in oocytes with low oolemma extensibility during ICSI by re-puncture the oocyte from another site.

Not Applicable
Conditions
Male infertility and failure to fertilize during in vitro fertilization
Registration Number
JPRN-UMIN000049763
Lead Sponsor
Sawada Women's Clinic
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
400
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are eligible for TESE or PESA. Patients with low fertilization rate by previous ICSI, or patients with severe oligozoospermia or teratozoospermia, who are indicated for oocyte activation. Patients who cannot give written consent to participate in this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Oocyte degeneration rate after ICSI
Secondary Outcome Measures
NameTimeMethod
Fertilization rate, blastocyst development rate, pregnancy rate, miscarriage rate
© Copyright 2025. All Rights Reserved by MedPath